Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Return on Equity (2016 - 2025)

Assembly Biosciences has reported Return on Equity over the past 11 years, most recently at 0.0% for Q4 2025.

  • For Q4 2025, Return on Equity rose 1.0% year-over-year to 0.0%; the TTM value through Dec 2025 reached 0.0%, up 1.0%, while the annual FY2025 figure was 0.0%, 1.0% up from the prior year.
  • Return on Equity for Q4 2025 was 0.0% at Assembly Biosciences, up from 0.0% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q4 2025 and troughed at 0.02% in Q2 2025.
  • A 5-year average of 0.01% and a median of 0.01% in 2022 define the central range for Return on Equity.
  • Biggest five-year swings in Return on Equity: fell -1bps in 2022 and later grew 1bps in 2025.
  • Year by year, Return on Equity stood at 0.01% in 2021, then tumbled by -50bps to 0.01% in 2022, then crashed by -47bps to 0.01% in 2023, then increased by 8bps to 0.01% in 2024, then skyrocketed by 98bps to 0.0% in 2025.
  • Business Quant data shows Return on Equity for ASMB at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.02% in Q2 2025.